The meningitis vaccines market size is USD 4.7 billion in 2026.
The meningitis vaccines market is projected to grow at a CAGR of 11% by 2033.
The meningitis vaccines market growth is driven by high disease burden, expanding immunization programs, and rising awareness.
Asia Pacific is the dominating region for the meningitis vaccines market.
GlaxoSmithKline plc, Pfizer Inc., Sanofi S.A., Merck & Co., Inc., and Serum Institute of India Pvt. Ltd. are some leading industry players in the meningitis vaccines market.